Year Begins With 5.4% Rise In Trade Deficit to $67 Billion
January 2024 posted a 5.4% gain in the monthly goods and services deficit, rising to $67.4 billion, the Bureau of Economic Analysis reported today.
January 2024 posted a 5.4% gain in the monthly goods and services deficit, rising to $67.4 billion, the Bureau of Economic Analysis reported today.
America’s largest generic drug supplier, Aurobindo, is riddled with safety and quality issues, including ties to overseas suppliers with links to China’s military.
Wolfe told the Commissioners on Monday that he doubts countries will be able to tolerate the deluge of China exports, adding that he sees no end in sight to this onslaught for the time being.
Three Southeast Asian nations have become China’s “Mini Me” when it comes to the solar supply chain.
The roughly 485 million packages that come into the U.S. duty free via the de minimis loophole is “overwhelming” and that volume “makes it harder for us to police products for consumer safety,” James Joholske, director of the office of import surveillance at the U.S. Consumer Product and Safety Commission (CPSC) told the U.S. China Economic and Security Review Commission on March 1
CPA Trade Counsel Charles Benoit and Chief Economist Jeff Ferry told Monday’s Prosperity Summit attendees that most economic models are worse at predicting trade outcomes than the local weatherman is at forecasting precipitation levels 10 days out.
Roughly 40 congressional staff members had a chance to meet with and hear from industry leaders as diverse as Florida farmers to multinational corporations in the renewable energy space about the trials and tribulations of competing with emerging markets that play by different rules. And often break existing ones.
“We are seeing a new consensus on trade. A lot of credit goes to President Trump and a lot of it goes to a bunch of working class Democrats,” Robert Lighthizer said at the first-ever Prosperity Summit.
Rep. Adrian Smith of the House Ways and Means trade subcommittee says the Generalized System of Preferences will be renewed, with retroactive tariff refunds worth billions.
Coalition vice presidents explain the FDAs shortcomings and why U.S. medicines are often in short supply in a new American Affairs Journal article.